Abstract
Treatment for metastatic disease to the liver involves understanding the full disease burden, including the primary tumor, and disease behavior. Dedicated liver imaging is essential to determine the number and distribution of hepatic lesions. The potential functional liver remnant must be ascertained. Depending on previously mentioned factors, surgical resection or liver-directed therapies can offer enhanced survival but must be balanced with systemic therapy, which should always be considered in metastatic disease. Surgery for the primary tumor should be considered in addition to the liver but may occur either in a staged or combined setting. Surveillance should occur following treatment to monitor for disease recurrence. Patients with hepatic disease that progresses on first-line chemotherapy should be switched to second-line therapy and monitored. For those who have disease that is unresectable and progressive, systemic therapy or a clinical trial remain the only options.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Covey AM, Brown KT, Jarnagin WR, et al. Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases. Ann Surg. 2008;247:451–5.
Poultsides GA, Servais EL, Saltz LB, et al. Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. JCO. 2009;27(20):3379–84.
NCCN Clinical Practice Guidelines in Oncology, Colon Cancer. Version 2.2017 – March 13, 2017. NCCN.org.
Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg. 2004;239:818–25.
Van Hazel GA, Heinemann V, Sharma NK, et al. SIRFLOX: randomized phase III trial comparing first-line mFOLFOX6 (plus or minus bevacizumab) versus mFOLFOX6 (plus or minus bevacizumab) plus selective internal radiation therapy in patients with metastatic colorectal cancer. JCO. 2016;34:1723–31.
Zacharias AJ, Jayakrishnan TT, Rajeev R, et al. Comparative effectiveness of hepatic artery based therapies for unresectable colorectal liver metastases: a meta-analysis. PLoS One. 2015;10:e0139940.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Mineyev, N.M., Chaffee, K.M., Wong, J. (2019). Malignant Liver Tumors (Metastatic Liver Disease). In: Docimo Jr., S., Pauli, E. (eds) Clinical Algorithms in General Surgery . Springer, Cham. https://doi.org/10.1007/978-3-319-98497-1_80
Download citation
DOI: https://doi.org/10.1007/978-3-319-98497-1_80
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-98496-4
Online ISBN: 978-3-319-98497-1
eBook Packages: MedicineMedicine (R0)